• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子β1通过不依赖SMAD的MEK-ERK1/2信号通路上调整合素αvβ3,从而诱导子宫内膜癌细胞的黏附和迁移。

TGFβ1 induces endometrial cancer cell adhesion and migration by up-regulating integrin αvβ3 via SMAD-independent MEK-ERK1/2 signaling.

作者信息

Xiong Siyuan, Klausen Christian, Cheng Jung-Chien, Leung Peter C K

机构信息

Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.

Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.

出版信息

Cell Signal. 2017 Jun;34:92-101. doi: 10.1016/j.cellsig.2017.03.010. Epub 2017 Mar 21.

DOI:10.1016/j.cellsig.2017.03.010
PMID:28336232
Abstract

Endometrial cancer is the most common, and second most lethal, gynecological malignancy, and its rates of incidence and death are growing. This is likely attributable to increased numbers of high-risk type II endometrial cancers which account for ~30% of cases but ~75% of deaths due to their aggressive and metastatic behaviour. Histopathological and in vitro functional studies suggest that aberrant TGFβ1 signaling may contribute to endometrial cancer development and the acquisition of invasive/metastatic characteristics. However, little is known about the cellular and molecular mechanisms of TGFβ1 in high-risk endometrial cancers. In the present study, we examined the roles and mechanisms of TGFβ1 on cell adhesion and motility in type II endometrial cancer cell lines, KLE and HEC-1B. We show that treatment with TGFβ1 increases cell adhesion to vitronectin and transwell cell migration. We also demonstrate that TGFβ1 treatment increases integrin β3 and αv mRNA and protein levels via SMAD-independent MEK-ERK1/2 signaling. Importantly, siRNA depletion or antibody-mediated blocking of integrin αvβ3 reversed the effects of TGFβ1 on cell adhesion and migration. Our results suggest that TGFβ1-MEK-ERK1/2-integrin αvβ3 signaling could contribute to the invasive behaviour of high-risk endometrial cancer by promoting cell adhesion and migration.

摘要

子宫内膜癌是最常见且致死率第二高的妇科恶性肿瘤,其发病率和死亡率正在上升。这可能归因于高危II型子宫内膜癌数量的增加,这类癌症约占病例的30%,但因其侵袭性和转移性导致约75%的死亡。组织病理学和体外功能研究表明,异常的TGFβ1信号传导可能促进子宫内膜癌的发展以及侵袭/转移特征的获得。然而,关于TGFβ1在高危子宫内膜癌中的细胞和分子机制知之甚少。在本研究中,我们研究了TGFβ1在II型子宫内膜癌细胞系KLE和HEC-1B中对细胞黏附和迁移的作用及机制。我们发现,用TGFβ1处理可增加细胞对玻连蛋白的黏附以及Transwell细胞迁移。我们还证明,TGFβ1处理通过不依赖SMAD的MEK-ERK1/2信号传导增加整合素β3和αv的mRNA及蛋白水平。重要的是,整合素αvβ3的siRNA敲低或抗体介导的阻断可逆转TGFβ1对细胞黏附和迁移的影响。我们的结果表明,TGFβ1-MEK-ERK1/2-整合素αvβ3信号传导可能通过促进细胞黏附和迁移导致高危子宫内膜癌的侵袭行为。

相似文献

1
TGFβ1 induces endometrial cancer cell adhesion and migration by up-regulating integrin αvβ3 via SMAD-independent MEK-ERK1/2 signaling.转化生长因子β1通过不依赖SMAD的MEK-ERK1/2信号通路上调整合素αvβ3,从而诱导子宫内膜癌细胞的黏附和迁移。
Cell Signal. 2017 Jun;34:92-101. doi: 10.1016/j.cellsig.2017.03.010. Epub 2017 Mar 21.
2
Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.激活素B通过SMAD2/3信号通路上调整合素β3,诱导人子宫内膜癌细胞的黏附、迁移和侵袭。
Oncotarget. 2015 Oct 13;6(31):31659-73. doi: 10.18632/oncotarget.5229.
3
Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway.转化生长因子β1通过β3整合素、c-Src和p38丝裂原活化蛋白激酶依赖性途径诱导人肺成纤维细胞中αvβ3整合素的表达。
J Biol Chem. 2008 May 9;283(19):12898-908. doi: 10.1074/jbc.M708226200. Epub 2008 Mar 18.
4
TGF-β1 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1/2 signaling pathways.转化生长因子-β1通过激活SMAD和ERK1/2信号通路下调PTEN,从而刺激II型子宫内膜癌细胞的迁移。
Oncotarget. 2016 Sep 20;7(38):61262-61272. doi: 10.18632/oncotarget.11311.
5
Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL signaling.激活素B通过不依赖SMAD的MEK-ERK1/2-SNAIL信号通路下调E-钙黏蛋白,从而促进子宫内膜癌细胞迁移。
Oncotarget. 2016 Jun 28;7(26):40060-40072. doi: 10.18632/oncotarget.9483.
6
Osteopontin Promotes Invasion, Migration and Epithelial-Mesenchymal Transition of Human Endometrial Carcinoma Cell HEC-1A Through AKT and ERK1/2 Signaling.骨桥蛋白通过AKT和ERK1/2信号通路促进人子宫内膜癌细胞HEC-1A的侵袭、迁移及上皮-间质转化
Cell Physiol Biochem. 2015;37(4):1503-12. doi: 10.1159/000438518. Epub 2015 Oct 29.
7
KCC1 gene advances cell invasion ability by regulating ERK signaling pathway in endometrial cancer HEC-1B cell line.KCC1 基因通过调节子宫内膜癌细胞系 HEC-1B 中的 ERK 信号通路促进细胞侵袭能力。
Int J Gynecol Cancer. 2011 Jul;21(5):795-9. doi: 10.1097/IGC.0b013e318216a169.
8
Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.持续的细胞外信号调节激酶(ERK)活性诱导整合素β3表达,促进转化生长因子β(TGFβ)诱导的间充质肿瘤细胞的侵袭能力。
Cancer Lett. 2016 Jul 1;376(2):339-46. doi: 10.1016/j.canlet.2016.04.012. Epub 2016 Apr 13.
9
Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.促性腺激素释放激素(GnRH)-I 和 GnRH-II 诱导人子宫内膜癌细胞生长抑制:整合素 β3 和粘着斑激酶的参与。
Reprod Biol Endocrinol. 2009 Aug 5;7:81. doi: 10.1186/1477-7827-7-81.
10
Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.Smad2在悬浮的胃癌细胞中介导TGF-β1诱导的Erk1/2激活,但在贴壁的胃癌细胞中则不然。
Int J Oncol. 2004 May;24(5):1229-34.

引用本文的文献

1
Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells.在不同代谢条件下,二甲双胍处理子宫内膜癌细胞后癌症和转移相关基因及蛋白表达的变化
Heliyon. 2023 May 25;9(6):e16678. doi: 10.1016/j.heliyon.2023.e16678. eCollection 2023 Jun.
2
Identification of an ALK-2 inhibitor as an agonist for intercellular exchange and tumor delivery of nanomaterial.鉴定一种ALK-2抑制剂作为纳米材料细胞间交换和肿瘤递送的激动剂。
Adv Ther (Weinh). 2023 Feb;6(2). doi: 10.1002/adtp.202200173. Epub 2022 Oct 17.
3
Integrated bioinformatics data analysis reveals a risk signature and PKD1 induced progression in endometrial cancer patients with postmenopausal status.
整合生物信息数据分析揭示了绝经后子宫内膜癌患者的风险特征和 PKD1 诱导的进展。
Aging (Albany NY). 2022 Jul 9;14(13):5554-5570. doi: 10.18632/aging.204168.
4
Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.子宫内膜癌中 MCMs 的表达和预后的多组学分析。
Biosci Rep. 2021 Dec 22;41(12). doi: 10.1042/BSR20211719.
5
Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study.临床及生化甲状腺功能障碍对子宫内膜癌生存结果有影响吗?一项前瞻性数据库研究。
Cancers (Basel). 2021 Oct 29;13(21):5444. doi: 10.3390/cancers13215444.
6
IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway.IL-37bΔ1-45 通过靶向 Rac1/NF-κB/MMP2 信号通路抑制子宫内膜癌细胞的迁移和侵袭。
Lab Invest. 2021 Jun;101(6):760-774. doi: 10.1038/s41374-021-00544-2. Epub 2021 Mar 22.
7
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival.整合素 αV(ITGAV)在食管腺癌中的表达与总生存期缩短相关。
Sci Rep. 2020 Oct 27;10(1):18411. doi: 10.1038/s41598-020-75085-7.
8
BDNF promoted osteoblast migration and fracture healing by up-regulating integrin β1 via TrkB-mediated ERK1/2 and AKT signalling.脑源性神经营养因子通过TrkB介导的细胞外信号调节激酶1/2(ERK1/2)和蛋白激酶B(AKT)信号通路上调整合素β1,从而促进成骨细胞迁移和骨折愈合。
J Cell Mol Med. 2020 Sep;24(18):10792-10802. doi: 10.1111/jcmm.15704. Epub 2020 Aug 16.
9
Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway.视黄醇脱氢酶 10 通过转化生长因子-β/SMAD 信号通路促进神经胶质瘤细胞的转移。
Chin Med J (Engl). 2019 Oct 20;132(20):2430-2437. doi: 10.1097/CM9.0000000000000478.
10
The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer.甲状腺激素在肝细胞增殖和肝癌中的作用
Front Endocrinol (Lausanne). 2019 Aug 30;10:532. doi: 10.3389/fendo.2019.00532. eCollection 2019.